Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A...

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Research

Background:

• Multivessel disease (MVD) complicates approximately 50% of acute coronary syndrome (ACS) cases, leading to poor prognoses and high mortality.
• Optimal management of MVD in ACS remains challenging, particularly regarding complete revascularization timing and intermediate stenosis guidance.
• Current guidelines offer some direction, but evidence is stronger for ST-elevation myocardial infarction than for non-ST-elevation myocardial infarction or cardiogenic shock.

Approach:

• A systematic review of existing evidence on percutaneous coronary revascularization in ACS patients with MVD was conducted.
• The review incorporates insights from ongoing clinical trials addressing different revascularization timing strategies.
• The role of invasive and noninvasive guidance techniques in managing intermediate stenoses is also considered.

Key Points:

• Complete revascularization benefits hemodynamically stable ACS patients with MVD.
• Uncertainties persist regarding optimal timing and guidance strategies for intermediate lesions.
• Future trials will compare different timing strategies and evaluate guidance techniques.

Conclusions:

• Further research is needed to clarify optimal revascularization strategies for ACS with MVD.
• Ongoing trials investigating timing and guidance techniques are crucial for advancing clinical practice.
• Systematic review highlights the need for evidence-based decision-making in complex MVD cases.